Navigation Links
MedShape Solutions, Inc. Announces First FDA-cleared Shape Memory PEEK Device; Closing of $10M Equity Offering
Date:9/23/2009

ATLANTA, Sept. 23 /PRNewswire/ -- MedShape Solutions, Inc. announced today the first FDA cleared shape memory PEEK (polyaryletheretherketone) device for orthopedics using proprietary shape memory PEEK Altera(TM) material. The Morphix(TM) Suture Anchor was recently granted FDA clearance and will be released to select U.S. markets in the coming months. Over $2.5B of PEEK-based implants are sold every year in the field of orthopedics. These devices range from spinal cages to suture anchors and across all sectors of orthopedics. As a material, PEEK provides excellent benefits such as strength, radiolucency and reliability.

"PEEK Altera(TM) is a proprietary shape memory material that will allow us to develop devices that will be 'dynamic' in nature versus the current PEEK technology which is 'static'," stated Chris Fair, MedShape Solutions' COO. The Morphix(TM) Suture Anchor system design takes advantage of the shape memory material and provides the clinician with superior fixation strength both in pull out as well as improved performance under cyclic loading. "Shape memory allows us to design and develop implants that can enter a cavity or bony tunnel in one diameter and deploy them to a much larger size. This shape change can drastically improve the strength profile of the device as well as improve the delivery environment. As an example, our 3.5mm Morphix(TM) device has a greater strength profile than most 5.5mm devices currently in the market," stated Ken Gall, PhD, founder and CTO of MedShape Solutions.

"What is unique about the Morphix(TM) device is the simplicity of its design coupled with outstanding performance when compared to competitive devices," stated orthopedic surgeon Bill Bryan, MD, Houston, TX. "I love the fact that the dynamic nature of the implant allows it to adjust to the surrounding changes in the bone that occur after cyclic loading. The Morphix(TM) is the only implant I am aware of that can do this."

MedShape Solutions also announced that it has recently closed approximately $10M of equity funding from various qualified private investors. "This recent round of financing will allow MedShape to bring forward several unique shape memory orthopedic devices that will improve patient outcomes and improve surgical procedures," stated Kurt Jacobus, PhD, President & CEO. "We continue to make progress in building a company of significant value centered around our shape memory technology platform."

Contact: Chris Fair, Chief Operating Officer, 404-249-9155, chris.fair@medshapesolutions.com

About MedShape Solutions, Inc.:

MedShape Solutions, Inc. is a privately held medical device company based in Atlanta, GA. MedShape Solutions is committed to creating and delivering unique shape memory based technologies in the field of orthopedics and to Shaping the Future of Orthopedics(TM). More information can be found at www.medshapesolutions.com


'/>"/>
SOURCE MedShape Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Cascade Microtech Introduces Worlds First 45 nm-capable DC/RF Parametric Probe Card Solutions, Lowers Cost of Ownership
2. Finesse Solutions, LLC Announces OPC Connectivity With Nova BioProfile 400
3. Abt Associates Clinical Trials Announces Name Change to Abt Bio-Pharma Solutions, Inc.
4. Premier Research Group plc and Octagon Research Solutions, Inc. Announce Strategic Partnership
5. VaxGen Sells Anthrax Vaccine Program and Related Assets and Technology to Emergent BioSolutions, Inc.
6. Abt Bio-Pharma Solutions, Inc. Names Nandini Hadker as Executive Director, Succeeding Susan Windham-Bannister
7. Mentice, Inc. and Education Management Solutions, Inc. Form OEM Partnership
8. Karen Walton-Bowen Joins Abt Bio-Pharma Solutions, Inc., as Senior Director, Biometrics
9. Jovianna DiCarlo Named ConsentSolutions, Inc. President & Chief Executive Officer
10. Hospira Announces New Contract With MedAssets for Intravenous Solutions, Renewal of Infusion Devices Agreement
11. NexInfo Solutions, Inc. Selected by Beckman Coulter to Design and Streamline Global Sales & Operations Planning Processes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... -- Beike Biotechnology, the Shenzhen ... in late 2015 to mark their successful combined efforts ... --> --> The signing, ... Therapy" was hosted by the Shenzhen Cell Bank and ... Beike Biotechnology Co., Ltd. Shenzhen,s ...
(Date:2/4/2016)... , February 4, 2016 ... a biotechnology acceleration company is pleased to provide the following ... --> Over the last 3 months we have ... securities purchase agreements exceeding $1,000,000. As a result, we have ... Mannin Research Inc. license agreement and expect that development to ...
(Date:2/4/2016)... Feb. 4, 2016 Sinovac Biotech Ltd. ("Sinovac" ... provider of biopharmaceutical products in China ... board of directors received on February 4, 2016 a ... a consortium comprised of PKU V-Ming ( Shanghai ... Ltd., CICC Qianhai Development ( Shenzhen ) ...
(Date:2/4/2016)... ... February 04, 2016 , ... Many of the engineers at FireflySci, ... What sets them apart from other cuvette manufacturers is their supercharged customer service ... On top of this steady flow of inside information, they have recently revamped ...
Breaking Biology Technology:
(Date:2/2/2016)... Technology Enhancements Accelerate Growth of X-ray Imaging ... and computed radiography markets in Thailand ... Indonesia (TIM). It provides an in-depth analysis ... as regional market drivers and restraints. The study offers ... market attractiveness, both for digital and computed radiography. Market ...
(Date:2/1/2016)... Canada , February 1, 2016 ... technological advancements to drive global touchfree intuitive gesture control ... --> Rising sales of consumer electronics coupled ... gesture control market size through ... consumer electronics coupled with new technological advancements to drive ...
(Date:1/28/2016)... -- Synaptics (NASDAQ: SYNA ), a leading developer of human ... December 31, 2015. --> --> ... 2 percent compared to the comparable quarter last year to $470.5 ... $35.0 million, or $0.93 per diluted share. ... quarter of fiscal 2016 grew 9 percent over the prior year ...
Breaking Biology News(10 mins):